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Transgene-Assisted Genetic Screen Identifies rsd-6 and Novel
Genes as Key Components of Antiviral RNA Interference in
Caenorhabditis elegans
Tianyun Long,a Fei Meng,a Rui Lua
aDepartment of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana, USA
ABSTRACT RNA interference (RNAi) is a widespread antiviral mechanism trig-
gered by virus-produced double-stranded RNAs (dsRNAs). In Caenorhabditis el-
egans, antiviral RNAi involves a RIG-I-like RNA helicase, termed DRH-1 (dicer re-
lated RNA helicase 1), that is not required for classical RNAi triggered by artificial
dsRNA. Currently, whether antiviral RNAi in C. elegans involves novel factors that
are dispensable for classical RNAi remains an open question. To address this
question, we designed and carried out a genetic screen that aims to identify
novel genes involved in worm antiviral RNAi. By introducing extra copies of
known antiviral RNAi genes into the reporter worms, we managed to reject al-
leles derived from 4 known antiviral RNAi genes, including the DRH-1 coding
gene, during the screen. Our genetic screen altogether identified 25 alleles,
which were assigned to 11 candidate genes and 2 known antiviral RNAi genes
through genetic complementation tests. Using a mapping-by-sequencing strat-
egy, we identified one of the candidate genes as rsd-6, a gene that helps main-
tain genome integrity through an endogenous gene-silencing pathway but was
not known to be required for antiviral RNAi. More importantly, we found that
two of the candidate genes are required for antiviral RNAi targeting Orsay virus,
a natural viral pathogen of C. elegans, but dispensable for classical RNAi. Since
drh-1 is so far the only antiviral RNAi gene not required for classical RNAi, we
believe that our genetic screen led to identification of novel worm genes that
may target virus-specific features to function in RNAi.
IMPORTANCE In nematode worms, drh-1 detects virus-produced double-stranded
RNA (dsRNA), thereby specifically contributing to antiviral RNA silencing. To identify
drh-1-like genes with dedicated function in antiviral RNAi, we recently carried out a
genetic screen that was designed to automatically reject all alleles derived from 4
known antiviral silencing genes, including drh-1. Of the 11 candidate genes identi-
fied, we found two of them to be required for antiviral silencing targeting a natural
viral pathogen of C. elegans but not for classical RNA silencing triggered by artificial
dsRNA. We believe that these two genes are novel components of worm antiviral
RNAi, considering the fact that drh-1 is the only known antiviral RNAi gene that is
dispensable for classical RNAi. This genetic screen also identified rsd-6, a gene that
maintains genome integrity under unfavorable conditions, as a key regulator of
worm antiviral silencing, demonstrating an interplay between antiviral immunity and
genome integrity maintenance.
KEYWORDS classical RNAi, antiviral RNAi, siRNA, biased genetic screen, rsd-6
Small interfering RNAs (siRNAs) processed from virus-derived double-stranded RNA(dsRNA) mediate potent antiviral RNA interference (RNAi) in diverse organisms (1).
Mechanistic studies of antiviral RNAi have led to the identification of several key factors
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involved in this process. Typically, an endoribonuclease III termed Dicer processes viral
dsRNA into siRNAs to initiate antiviral RNAi (2). Subsequently, an Argonaute protein, a
type of endoribonuclease with an RNase H-like fold, recruits virus-derived siRNAs
(vsiRNAs) as sequence guides and cleaves viral transcripts containing complementary
sequence. dsRNA binding proteins also contribute to antiviral RNAi by facilitating viral
dsRNA processing or vsiRNA loading into Argonaute proteins (3–5). In plants and
nematodes antiviral RNAi is further amplified through the production of secondary
vsiRNAs by RNA-dependent RNA polymerase (6–9). Recently, antiviral RNAi was ob-
served in undifferentiated mammalian cells and appears to provide protection against
the attack of lethal viral pathogens for suckling mice (10, 11). Since viral diseases are
often the result of perturbation of host antiviral RNAi in diverse organisms (12, 13),
mechanistic study of antiviral RNAi holds promise for developing novel antiviral strat-
egies.
Orsay virus naturally infects Caenorhabditis elegans nematodes (14), providing an
ideal genetic model system for the study of virus-host interactions, including antiviral
RNAi. Genetic and biochemical analyses suggest that antiviral RNAi in C. elegans is
initiated by the worm Dicer DCR-1, which processes viral dsRNA into primary vsiRNAs,
predominately 23 nucleotides in length (4, 15, 16). Efficient processing of viral dsRNA
by DCR-1 requires a dsRNA-binding protein termed RDE-4 (RNAi defective 4) (4, 5, 17,
18). The primary vsiRNAs are then loaded into RDE-1, one of the worm Argonaute (Ago)
proteins that has slicer activity (4, 17–19). Instead of cleaving viral transcripts with
matching sequence, RDE-1 loaded with primary vsiRNA activates, probably with help
from cofactors, RRF-1, a worm RNA-dependent RNA polymerase (RdRp) (19, 20). Sub-
sequently, activated RRF-1 synthesizes secondary siRNAs in a DCR-1-independent
manner (6, 8, 21–23). Unlike primary vsiRNAs produced by DCR-1, secondary vsiRNAs
are single-stranded RNA molecules of 22 nucleotides and carry a triphosphate group at
the 5= end (22–24).
Antiviral RNAi in C. elegans also requires DRH-1 (Dicer-like RNA helicase 1) and
DRH-3, two RIG-I-like RNA helicases (RLHs) that are not conserved in fungi, plants, or
insects (16, 25). Previously we found that the C-terminal regulatory domain of human
RIG-I protein, which contributes to virus sensing in mammalian innate immunity
(26–29), can functionally replace the corresponding domain in DRH-1, suggesting a role
of DRH-1 in virus sensing (8). Consistent with this, virus-derived vsiRNAs were found to
be significantly reduced in drh-1 mutants (6, 8). Currently, it remains largely unknown
whether DRH-1-mediated virus sensing involves additional factors and how the func-
tion of DRH-1 is regulated in response to virus invasion. Although sharing sequence
homology and domain structure with DRH-1, DRH-3 appears to function downstream
of DRH-1 and is required for the production of secondary vsiRNA (6, 8). DRH-3 also plays
an essential role in worm development (30). Currently exactly what DRH-3 does in
antiviral RNAi remains largely unknown.
RSD-2 is another key component of worm antiviral RNAi and appears to be con-
served only in the nematode kingdom (16, 31, 32). Previously we have shown that
RSD-2 contributes to both RDE-4-dependent and RDE-4-independent antiviral RNAi
(31). Consistent with a prior study on classical RNAi (33), we found that vsiRNAs can by
readily detected by Northern blotting in rsd-2 mutants with a size distribution similar to
that in rde-1 and rrf-1 mutants, suggesting that RSD-2 is dispensable for the biogenesis
of primary vsiRNAs and contributes to the amplification of antiviral RNAi by facilitating
the production of secondary vsiRNAs (31). Recently, a Vasa ATPase-related protein,
termed RDE-12, was also found to contribute to antiviral RNAi, probably by enabling
the production of secondary vsiRNA (34).
Previously we have shown that high-level viral replication in drh-1 mutants led to
the production of vsiRNAs at low levels (8). This observation, together with a recent
report, suggests a drh-1-independent mechanism for the production of vsiRNAs in C.
elegans (35). Notably, these vsiRNAs are capable of mediating potent silencing of a
homologous transgene (8). Similarly, silencing of transgenes but not homologous virus
can also be triggered in drh-1 mutants when RNAi is induced using artificial dsRNA (8).
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These findings together suggest that viruses are more resistant to RNAi than homol-
ogous cellular transcripts, and as such additional genes may be required for antiviral
RNAi. Apparently, these antivirus-specific genes can only be identified in genetic
screens where replicating viruses are used as reporters of loss of RNAi.
Orsay virus is a plus-strand RNA virus with a bipartite genome that resembles
nodavirus in terms of structure and sequence homology. Orsay virus only infects
intestine cells of C. elegans, and such a tissue-specific infection pattern remains un-
changed when the virus was delivered into wild-type worms or RNAi-defective mutants
as a transgene known to be active in nonintestinal cells (36). These observations
suggest that there is a receptor- and RNAi-independent mechanism that restricts
systemic spreading of Orsay virus in C. elegans. Orsay virus replicates at low levels in
wild-type N2 worms but accumulates to high levels in RNAi-defective mutants or in the
presence of a functional RNAi suppressor (6, 8, 31, 37). These observations, together
with the fact that Orsay virus was originally isolated from a worm isolate naturally
defective in antiviral RNAi, suggest that Orsay virus has very weak, if any, activity in
RNAi suppression (14). Currently a modified Orsay virus derivative that would allow for
the visualization of loss of antiviral RNAi in C. elegans is still lacking. Thus, genetic
screens that aim to identify novel antiviral RNAi genes through genetic screen will need
to seek an alternative model virus as a reporter for loss of antiviral RNAi.
To identify novel genes with dedicated function in antiviral RNAi, we have recently
carried out a large-scale genetic screen that utilized a flock house virus (FHV) replicon
as the loss-of-RNAi reporter (16). By integrating extra copies of four known antiviral
RNAi genes into the reporter transgene array, we expected to automatically reject
genetic alleles derived from those four genes during genetic screening. Upon com-
pleting such a biased genetic screen, we isolated 25 genetic alleles that were assigned
to 11 candidate genes and two known RNAi genes. Most importantly, we found that
two of the candidate genes are required for antiviral RNAi targeting Orsay virus but
dispensable for classic RNAi. Since drh-1 alleles have been excluded during the screen,
we believe that these two candidate genes are a novel requirement of worm antiviral
RNAi. Using a mapping-by-sequencing strategy, we also identified one candidate gene
as rsd-6. rsd-6 plays a role in endogenous gene silencing that helps maintain genome
integrity but was not known to be required for antiviral RNAi. Our study thus revealed
an interplay between antiviral immunity and an endogenous gene silencing pathway
that maintains genome integrity.
RESULTS
The design of a biased genetic screen for the identification of C. elegans genes
required for antiviral RNAi. FHV is a member of the Nodaviridae family. Although not
a pathogen of nematode worms, when delivered as a transgene, FHV replicates and
triggers potent antiviral RNAi in C. elegans (16), making it an alternative model virus for
the study of RNAi-mediated virus-host interaction in C. elegans (8, 17, 31, 37–39). Most
importantly, an FHV RNA1 derivative, named FR1gfp, has been successfully developed
as a reporter for loss of antiviral RNAi in C. elegans (Fig. 1A) (16). FR1gfp features an
enhanced green fluorescent protein (eGFP) coding sequence in place of B2 coding
sequence and produces bright green fluorescence in worm mutants defective in RNAi.
Thus, FR1gfp combined with a large-scale genetic screen will allow for the identification
of novel genes involved in antiviral RNAi.
So far, 10 C. elegans genes, including dcr-1, drh-1, drh-3, mut-7, rde-1, rde-2, rde-4,
rde-12, rrf-1, and rsd-2, have been implicated in antiviral RNAi through genetic analysis
(4, 6, 8, 16–18, 31, 34). Since most of these genes, with the exception of dcr-1, drh-3, and
mut-7, are dispensable for worm development, a conventional forward genetic screen
that aims to identify novel genes involved in antiviral RNAi may inevitably and
repetitively pick up loss-of-function alleles derived from some of these genes.
In C. elegans, gonad microinjection of target gene constructs often leads to the
formation of large transgene arrays that contain many copies of target genes (40). Since
the formation of those large transgene arrays does not rely on the sequence homology
Biased Genetic Screen for Antiviral RNAi Journal of Virology
























































shared between the injected genes, it is possible to generate a large transgene array
that contains many different transgenes. This observation suggests that we can code-
liver the FR1gfp reporter and several transgenes corresponding to known antiviral RNAi
genes into the worm strain to be used for the genetic screen. Since the chance to
simultaneously mutate both the transgenes and corresponding endogenous genes will
be extremely low, considering the fact that most of the transgenes will be delivered in
multiple copies, genetic screens utilizing this novel worm strain will automatically reject
null alleles derived from the known antiviral RNAi genes chosen to be excluded during
the screen. Therefore, to better understand worm antiviral RNAi, we have developed an
experimental strategy, as shown in Fig. 1, for identifying and characterizing worm
genes with dedicated function in antiviral RNAi. In this strategy, a reporter transgene
array is created to contain both a heat-inducible FR1gfp transgene and transgenes
constitutively expressing four of the known antiviral RNAi genes, drh-1, rde-1, rde-4, and
rsd-2 (Fig. 1A). The FR1gfp transgene serves as a loss-of-antiviral-RNAi reporter, whereas
the other 4 transgenes ensure that no loss-of-function alleles corresponding to these
genes will be isolated during the genetic screens. Following the genetic screen the
candidate mutants will be subjected to classical RNAi test to see whether they specif-
ically contribute to antiviral RNAi (Fig. 1B).
Generation of a reporter transgene array for biased genetic screen. To generate
a worm strain that contains both a heat-inducible FR1gfp transgene and transgenes
corresponding to drh-1, rde-1, rde-4, and rsd-2, we combined six plasmid constructs, as
shown in Fig. 1A, and injected them into rde-1;rde-4 double mutants that already
contain a heat-inducible FR1gfp transgene. This microinjection led to the production of
5 transgenic lines that contain transmissible extrachromosomal arrays. To find out
whether the rde-1 and rde-4 transgenes in these extrachromosomal arrays are func-
tional, we checked the expression of green fluorescence in the transgenic animals after
heat induction. Although a few worms occasionally showed green fluorescence in
pharyngeal tissue, none of the transgenic animals, marked by red fluorescence in the
head, produced whole-body green fluorescence (Fig. 2A), confirming that both rde-1
and rde-4 transgenes in those extrachromosomal transgene arrays are functional. To
generate a reporter strain for genetic screens, we treated one of the transgenic lines
create plasmids for constitutive expression
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FIG 1 Design of a biased genetic screen for the identification of novel C. elegans genes involved in antiviral
RNAi. (A) Schematic structure of plasmid constructs to be used to create the reporter transgene array for
biased genetic screen. HIP, heat-inducible promoter; protein A, the replicase of Flock house virus; Rz,
self-cleaving ribozyme sequence derived from hepatitis D virus, which functions to remove all nonviral
sequence at the 3= end of the FR1gfp primary transcripts; GFP, the coding sequence of enhanced green
fluorescence protein; Psur-5, the promoter of the endogenous gene sur-5; UTR, the 3=-end untranslated
region of unc-54; Pmyo-2, the myo-2 promoter which directs gene expression in pharyngeal muscles. (B) The
workflow for identification of worm genes required for antiviral RNAi.
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with gamma ray irradiation and screened the F2 worms for integrated transgene arrays.
This led to the identification of 3 integrated transgene arrays in total. By checking the
production of green fluorescence in response to heat induction, we confirmed that all
of these integrated transgene arrays contain functional rde-1 and rde-4 transgenes. We
chose one of the integrated transgene arrays, termed ty48, for further characterization
mainly because worms carrying this transgene array are free of any developmental
defects.
After introducing the ty48 transgene array into nontransgenic rde-1;rde-4 double
mutants through outcross, we performed Northern blot analyses to detect the repli-
cation of FR1gfp and Orsay virus in the resulting worm strain. As shown in Fig. 2B and
C, neither of the viruses was able to replicate at high level, and accordingly, no
whole-body green fluorescence was observed after heat induction (data not shown).
However, when rde-1;rde-4 double mutants carrying the ty48 transgene array were fed
with E. coli food expressing either rde-1 or rde-4 dsRNA, enhanced Orsay virus replica-
tion was detected through Northern blot analyses (Fig. 2D), suggesting that the
restoration of antiviral RNAi in the double mutants is indeed due to the introduction of
functional rde-1 and rde-4 transgenes. As shown in Fig. 2E, rde-4 dsRNA feeding led to
the production of whole-body green fluorescence in the double mutants after heat
induction, suggesting that the FR1gfp transgene was successfully integrated into the
ty48 transgene array.
Both drh-1 and rsd-2 transgenes are functional in the ty48 transgene array. To
find out whether drh-1 and rsd-2 transgenes have also been successfully integrated in
the transgene array ty48, we transferred ty48 into drh-1 and rsd-2 mutants through
outcross and checked FR1gfp replication in the resulting worm strains after heat
induction. We found that, as shown in Fig. 3A, the ty48 transgene array successfully
FIG 2 Generation of reporter transgene array ty48. (A) Coinjection of the plasmid constructs shown in
Fig. 1A restored antiviral RNAi in rde-1;rde-4 double mutants that contain an FR1gfp transgene. Shown
here is the visualization of green fluorescence in the rde-1;rde-4 double mutants that contain extrach-
romosomal arrays formed by the injected plasmids 48 h after heat induction. The image was produced
by merging images recorded under red and green fluorescence using the same exposure. (B) Accumu-
lation of FR1gfp transcripts in single and double mutants corresponding to rde-1 and rde-4 as indicated.
An asterisk indicates worms that carry the ty48 transgene array. The FR1gfp transcripts were detected by
Northern blotting, for which the probe was prepared using GFP coding sequence; RNA1, FR1gfp genomic
RNA; RNA3, FR1gfp subgenomic RNA. Methylene blue-stained rRNA serves as an equal loading control.
(C) Northern blot detection of Orsay virus RNA1, ovRNA1, in single and double mutants corresponding
to rde-1 and rde-4 as indicated. An asterisk indicates worms that carry the ty48 transgene array. Orsay
virus RNA1 cDNA was used to prepare probe for the detection of Orsay virus RNA1 through Northern
blotting. (D) Accumulation of Orsay virus RNA1 in response to rde-1 or rde-4 dsRNA feeding in rde-1;rde-4
double mutants with or without the ty48 transgene array. An asterisk indicates worms that were fed with
E. coli food expressing rde-1 dsRNA. A double asterisk indicates worms that were fed with E. coli food
expressing rde-4 dsRNA. (E) The FR1gfp transgene in the transgene array ty48 is functional. Shown here
is the visualization of green fluorescence in the wild-type N2 worms carrying the ty48 transgene array 48
h after heat induction. The worms have been fed using E. coli food expressing rde-4 dsRNA.
Biased Genetic Screen for Antiviral RNAi Journal of Virology
























































restored antiviral RNAi in drh-1 and rsd-2 mutants, leading to the suppression of FR1gfp
replication. Moreover, no whole-body green fluorescence was observed in mutant
worms containing the ty48 transgene array (data not shown). We found that the
replication of Orsay virus was also suppressed to a level comparable to that in wild-type
N2 worms containing the same transgene array (Fig. 3B). Apparently, the restoration of
antiviral RNAi in both mutants can only be ascribed to the introduction of the ty48
transgene array, since the replication of both FR1gfp and Orsay virus was restored when
the expression of drh-1 and rsd-2, from both the endogenous genes and transgenes,
were suppressed through feeding RNAi (Fig. 3A and B). These results together suggest
that both drh-1 and rsd-2 transgenes were successfully integrated into the ty48
transgene array.
Antiviral RNAi remains defective in drh-3 and rrf-1 mutants containing the ty48
transgene array. The RNA-dependent RNA polymerase RRF-1 contributes to antiviral
RNAi by synthesizing the secondary vsiRNAs (5, 15, 20, 41, 42). Although secondary
vsiRNAs become undetectable in the absence of DRH-3, it is possible that DRH-3 does
more than facilitate the production of secondary vsiRNAs, as both FHV and Orsay virus
accumulate to higher levels in drh-3 mutants than that in rrf-1 mutants (8). To find out
whether the ty48 transgene array is sensitive enough to pick up genetic mutations that
disrupt antiviral RNAi, we introduced the ty48 transgene array into drh-3 and rrf-1
mutants and checked the replication of both FR1gfp and Orsay virus in the resulting
worm strains. We found that, as shown in Fig. 4A and B, FR1gfp replicated to high levels
in both drh-3 and rrf-1 upon heat induction, leading to the production of green
fluorescence in the resulting worm strains. Consistent with this, enhanced Orsay virus
replication was also detected in both mutant strains compared to that in wild-type N2
worms containing the same transgene array (Fig. 4C). Importantly, we found that both
FR1gfp and Orsay virus accumulated to higher levels in drh-3 mutants than that in rrf-1
mutants, and accordingly drh-3 mutants produced green fluorescence with higher
intensity than that from rrf-1 mutants (Fig. 4B). These results together suggest that we
have successfully developed a transgene array that can be used as a reporter for the
identification of loss of antiviral RNAi mutations in large-scale genetic screens. Since the
heat-inducible promoter used in this study is active in most worm cells and the FR1gfp
replicon is not capable of cell-cell movement, a genetic screen utilizing ty48 as a
reporter is expected to allow us to identify antiviral RNAi genes that function in a
cell-autonomous manner.
Identification of novel antiviral RNAi genes through large-scale genetic screen.
To identify novel genes involved in worm antiviral RNAi, we carried out a large-scale
FIG 3 Both drh-1 and rsd-2 transgenes are functional in the ty48 transgene array. (A) Northern blot
detection of FR1gfp replication in transgenic worm strains, as indicated, that contain the ty48 transgene
array after heat induction. See the legend to Fig. 2B for experimental details. An asterisk indicates worms
that were fed with E. coli food expressing drh-1 dsRNA. A double asterisk indicates worms that were fed
with E. coli food expressing rsd-2 dsRNA. (B) Accumulation of Orsay virus RNA1 in drh-1 and rsd-2 mutants
and wild-type N2 worms that carry the ty48 transgene array. An asterisk indicates worms that were fed
with E. coli food expressing drh-1 dsRNA. A double asterisk indicates worms that were fed with E. coli food
expressing rsd-2 dsRNA. See the legend to Fig. 2C for experimental details.
Long et al. Journal of Virology
























































genetic screen using N2 worms carrying the ty48 transgene array as a reporter. We used
ethyl methane sulfonate (EMS) as a mutagen to introduce random mutations into the
reporter worms by following a standard protocol. To reduce allele duplicates we
bleached F1 worms and collected the eggs for screening. After heat induction we
picked up F2 worms that produced green fluorescence at a level higher than or equal
to that in rrf-1 mutants carrying the same ty48 transgene array for further analysis. This
screen led to the identification of 25 alleles that compromised antiviral RNAi. To find
out whether any of these alleles were temperature-sensitive alleles, we checked the
fertility of the corresponding worms when they were maintained at 25°C. This test
identified 1026f, 1027e, 1103a, and 1026g as temperature-sensitive alleles (Table 1).
Worms carrying these alleles also exhibited developmental defects such as reduced
brood size. The fertility of the rest of the 21 mutants was not significantly affected by
elevated temperature. However, worms carrying 1026a, 1031a, 1031f, and 1105a alleles
also exhibited reduced brood size, whereas worms with 1030c produced dead eggs and
more males than wild-type N2 worms under normal growth conditions. Together, these
observations suggest that some of the identified genes play important roles in worm
development.
To determine the dominance of the identified alleles, we performed crosses be-
tween the identified mutants and wild-type N2 worms and checked the occurrence of
loss of antiviral RNAi phenotype in the F2 generations. This test confirmed that all of the
identified alleles were recessive (data not shown). Through genetic complementation
tests we successfully assigned the identified alleles to 13 distinct genes, here referred
to as antiviral silencing-defective (asd) genes (Table 1). Interestingly, all temperature-
sensitive alleles, which also exhibit similar developmental defects, were assigned to a
single gene, asd-1. To find out whether any of our candidate genes are known antiviral
RNAi genes, we performed extensive genetic complementation tests between our
candidate worms and worm strains that contain loss-of-function alleles corresponding
to drh-1, drh-3, rde-1, rde-2, rde-3, rde-4, rde-10, rde-11, rrf-1, and rsd-2. These tests not
only identified asd-6 and asd-13 as rde-3 and rrf-1 (Table 1) but also confirmed that
none of the remaining 11 genes are drh-1, rde-1, rde-4, rsd-2, or drh-3 (Table 1). Through
cDNA sequencing we found that the 1025a allele of rrf-1 contains a point mutation that
caused an alteration from glycine to aspartic acid at position 540 of RRF-1, whereas the
1026e allele of rrf-1 carried a premature stop codon after the first 96 codons (Fig. 5A).
The 1031b allele of rde-3 contains a premature stop codon, causing a deletion of 350
amino acids (aa) at the C terminus of RDE-3 protein, which is 441 aa in total (Fig. 5B).
We believe that 1026e and 1031b are null alleles for rrf-1 and rde-3, respectively. To
reconfirm that it is the mutation in the 1031b allele that caused the loss of antiviral
RNAi, we injected the mutant worms with plasmid expressing wild-type RDE-3. As
expected, ectopic expression of wild-type RDE-3 indeed restored the antiviral silencing
(Fig. 5C). In addition to rrf-1, multiple alleles were also identified for asd-1, asd-2, asd-3,
FIG 4 Antiviral RNAi remains defective in rrf-1 and drh-3 mutants containing the ty48 transgene array. (A)
Northern blot detection of FR1gfp replication in rrf-1 and drh-3 mutants, as indicated, that contain the
ty48 transgene array. See the legend to Fig. 2B for experimental details. (B) Visualization of green
fluorescence in rrf-1 and drh-3 mutants, as indicated, carrying the ty48 transgene array 48 h after heat
induction. These images were produced by merging images recorded using the same exposure and at
the same time. (C) Accumulation of Orsay virus RNA1 in rrf-1 and drh-3 mutants that carry the ty48
transgene array.
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asd-4, and asd-5 (Table 1). We noticed that alleles for most of these 5 candidate genes
appeared to have been isolated from different batches of mutagenized worms, sug-
gesting that they are independent alleles. The identification of rde-3 and rrf-1 alleles
together with the fact that distinct alleles were also picked up for several other
candidate genes suggests that our biased genetic screen had a comprehensive cover-
age on antiviral RNAi genes for which the antiviral function can be compromised
without sacrificing worm viability.
Functional characterization of the identified candidate genes. With a replicating
virus as the trigger and target of RNAi, our genetic screen was expected to identify
genes with specific function in antiviral RNAi but not in classical RNAi. To determine
whether any of the candidate genes contributed specifically to antiviral RNAi, we tested
whether their function in RNAi was triggered by dsRNA ingestion. We did not use the
original mutants for this test, considering that some of the random mutations in
the original mutants may have adverse effects on feeding RNAi. Our test began with the
introduction, through outcross, of the representative allele for each of the 11 asd genes
into a transgenic worm strain, termed LR11 (Fig. 6A, upper). LR11 worms contain two
physically linked transgenes, a heat-inducible FR1gfp transgene and an mCherry trans-
gene driven by the myo-3 promoter (Fig. 6A, lower). The FR1gfp transgene produces
green fluorescence upon heat induction when antiviral RNAi is defective, whereas the
mCherry transgene directs constitutive expression of mCherry in body wall muscle and
serves as the target of feeding RNAi. After homozygous alleles corresponding to the
identified genes were introduced into LR11 worms, as confirmed by visualization of
TABLE 1 Loss of antiviral RNAi alleles isolated in the biased genetic screen
Candidate gene Allele
Strength of green
fluorescencea Temp sensitivityb Developmental defect
asd-1 1026f   Reduced brood size
1027e   Reduced brood size
1103a   Reduced brood size
1026g   Reduced brood size
asd-2 1026b   
1028g   
1029e   
asd-3 1029c   
1031e   
1102b   
asd-4 1025b   
1028f   
1029b   
asd-5 1026a   Reduced brood size
1031a   Reduced brood size
1031f   Reduced brood size
asd-6 (rde-3) 1031b   
asd-7 1028j   
asd-8 1030d   
asd-9 1026d   
asd-10 1105a   Reduced brood size
asd-11 1030c   High frequency of males
asd-12 1026c   
asd-13 (rrf-1) 1025a   
1026e   
aThe GFP expression level in drh-3 and rrf-1 mutants was used as a reference. Candidate mutants that
produce green fluorescence at a level higher than or equal to that in rrf-1 mutants carrying the same ty48
transgene array are marked as . Candidate mutants producing green fluorescence at a level higher
than or equal to that in drh-3 mutants are marked as .
bCandidate mutants that are sterile at 25°C are defined as temperature-sensitive mutants.
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green fluorescence after heat induction, we checked RNAi response in the resulting
worms upon mCherry dsRNA ingestion. We reasoned that mCherry dsRNA ingestion
would lead to the silencing of mCherry expression in body wall muscle if the allele
specifically disrupted antiviral RNAi but not classical RNAi. In contrast, no mCherry
silencing should occur if the tested allele disrupts both classical RNAi and antiviral RNAi.
We found that, as shown in Fig. 6B, C, and D, although enhanced FR1gfp replication was
detected at comparable levels, mCherry silencing was observed for alleles correspond-
ing to asd-2, asd-3, asd-4, asd-7, asd-8, asd-9, asd-10, asd-11, and asd-12 but not for
alleles corresponding asd-1, asd-5, and asd-6 (rde-3). As a reconfirmation, we subjected
the same set of worms to feeding RNAi tests in which the endogenous genes skn-1 and
unc-22 were chosen as the targets of RNAi. Again, as shown in Table 2, penetrating RNAi
phenotypes, manifested as dead eggs and twitching progenies, were observed for
alleles corresponding to asd-2, asd-3, asd-4, asd-7, asd-8, asd-9, asd-10, asd-11, and
asd-12 but not for asd-1, asd-5, and asd-6 (rde-3). To rule out the possibility that the
differential requirement of the identified genes in classical RNAi is an artifact associated
with dsRNA feeding, we tested the same set of worm mutants in RNAi response
triggered by unc-22 dsRNA microinjection. As shown in Fig. 6E and F, injection of unc-22
dsRNA at a concentration of 100 ng/l induced severe twitching phenotypes in the
progenies of injected N2 worms and LR11 worms carrying drh-1 null allele tm1329 and
rrf-1 null allele ok589 but not in LR11 worms carrying rde-4 null allele ne337. The same
treatment induced a strong twitching phenotype for progeny worms corresponding to
asd-2, asd-3, asd-4, asd-7, asd-8, asd-9, asd-10, asd-11, and asd-12 but not for progeny
worms corresponding to the rest of the asd genes. These observations together suggest
that nine of our candidate genes mainly function in antiviral silencing but not classical
RNAi.
Identification of asd-5 as rsd-6 through whole-genome sequencing. Worms
containing 1026a, 1031a, and 1031f alleles lay fewer eggs than wild-type worms but are
generally healthy and exhibit normal mobility. To gain insight into the genetic identity
of asd-5, we used the mapping-by-sequencing strategy to identify one of its alleles,
FIG 5 Identification of rrf-1 and rde-3 alleles that are defective in antiviral RNAi. (A) Identification of point
mutations in rrf-1 coding sequence that disrupt rrf-1 function in antiviral RNAi. Shown here is the rrf-1
cDNA sequencing results for rrf-1 alleles 1025a and 1026e. The rrf-1 coding sequence in wild-type worm
N2 was sequenced as a reference. (B) Point mutations in rde-3 allele 1031b that disrupt antiviral RNAi. The
rde-3 coding sequence in wild-type worm N2 was sequenced as a reference. (C) Ectopic expression of
wild-type rde-3 restored antiviral RNAi in worm mutants containing the 1031b allele. (Upper) Structure
of plasmid construct that expresses wild-type rde-3. (Lower) Visualization of antiviral RNAi in worms
containing the 1031b allele. Worms marked with red fluorescence in the head region contain a transgene
that expresses wild-type rde-3.
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1026a. Using an in-house-developed workflow, as illustrated in Fig. 7, we mapped the
1026a allele to a point mutation in worm gene rsd-6. By sequencing rsd-6 cDNA we
confirmed that a C-to-T point mutation at position 367 has caused a premature stop
codon in rsd-6 coding sequence in the 1026a worms, and such a mutation led to the
deletion of the last 567 aa of RSD-6 protein, which is 689 aa in length (Fig. 8A).
Importantly, point mutations that caused premature stop codons in rsd-6 coding
sequence were also identified for another two asd-5 alleles, 1031a (C-to-T change at
FIG 6 Function characterization of the candidate genes. (A) Experimental design for the introduction of candidate
alleles into worm strain LR11. m, loss-of-function alleles identified in the biased genetic screen. Pmyo-3, myo-3
promoter that is constitutively active in body wall muscle. (B) Northern blot detection of FR1gfp replication in LR11
worms that contain genetic alleles corresponding to asd-1, asd-5, and rde-3. The replication of FR1gfp was also
detected in wild-type N2 worms and drh-1 and rde-4 mutants as references. (C) Northern blot detection of FR1gfp
replication in LR11 worms that contain genetic alleles corresponding to asd-2, asd-3, asd-4, asd-7, asd-8, asd-9,
asd-10, asd-11, and asd-12. (D) Visualization of mCherry fluorescence in LR11 worms that contain genetic alleles
corresponding to candidate alleles, as indicated within each set of images. All worms were fed using E. coli food
expressing dsRNA derived from mCherry coding sequence. The inset images were taken under white light. All
images were taken using the same exposure. (E and F) unc-22 RNAi phenotype observed in LR11 worms containing
genetic alleles, as indicated in panels B and C, corresponding to candidate genes. unc-22 dsRNA was injected at a
concentration of 100 ng/l. Shown here are the percentages of twitching F1 progenies of the injected worms
collected between 8 and 32 h postinjection. The error bars indicate standard deviations for the twitching
phenotype.
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position 241) and 1031f (G-to-A change at position 213). We believe that all of these
new rsd-6 alleles are null alleles, considering the large deletions in the RSD-6 C-terminal
half for these alleles (Fig. 8A). To reconfirm that asd-5 is indeed rsd-6, we created an
RSD-6-expressing construct (Fig. 8B) and used it to inject worms containing the 1026a
allele. We reasoned that if the loss of antiviral RNAi in 1026a worms is caused by genetic
mutations in rsd-6, ectopic expression of wild-type rsd-6 will restore antiviral RNAi in
1026a worms. As shown in Fig. 8C, antiviral RNAi was indeed restored in all 1026a
worms that carry the extrachromosomal arrays formed by the Psur-5::rsd-6 transgene
(Fig. 8C, compare worms with red fluorescence in the head to worms without).
Consistent with this, FHV and Orsay virus replication was significantly reduced in 1026a
worms that contain the integrated transgene corresponding to the injected construct
(Fig. 8D and E). Based on these results, we conclude that asd-5 is actually rsd-6. rsd-6 is
known to be engaged in an endogenous gene-silencing pathway that helps maintain
genome integrity under unfavorable conditions (43, 44). Thus, our study for the first
time identified an interplay between antiviral innate immunity and the mechanism that
maintains genome integrity.
asd-2 and asd-9 are required for RNAi targeting Orsay virus. To find out whether
the identified genes are required for antiviral RNAi against Orsay virus, we checked
Orsay virus replication in LR11 worms containing the identified alleles. As shown in Fig.
9A, although enhanced Orsay virus replication was detected for alleles corresponding
to asd-1, asd-2, asd-5 (rsd-6), asd-6 (rde-3), and asd-9, such an enhancement was not
detected for alleles corresponding to asd-3, asd-4, asd-7, asd-8, asd-10, asd-11, and
asd-12. As a reconfirmation, we checked Orsay virus replication in original mutants
isolated from the genetic screen. As shown in Fig. 9B, enhanced viral replication was
detected for all alleles corresponding to asd-1, asd-2, asd-5, and asd-9 but not for any
alleles corresponding to asd-3, asd-4, asd-7, asd-8, asd-10, asd-11, and asd-12. These
TABLE 2 Sensitivity of the identified mutants to feeding RNAi targeting skn-1 and unc-22a









asd-2 1026b  
1029e  
1028g  
asd-3 1029c  
1031e  
1102b  
asd-4 1025b  
1028f  
1029b  
asd-5 1026a  
1031a  
1031f  
asd-6 (rde-3) 1031b  
asd-7 1028j  
asd-8 1030d  
asd-9 1026d  
asd-10 1105a  
asd-11 1030c  
asd-12 1026c  
aThe sensitivity to skn-1 dsRNA feeding was recorded as whether the eggs laid by the treat worms can
hatch. The sensitivity to unc-22 dsRNA feeding was recorded as whether the progenies of the treated
worms display twitching phenotype. , not sensitive; , sensitive.
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results, together with the results shown in Fig. 6, suggest that asd-2 and asd-9 are genes
that play important roles in natural antiviral defense mediated by RNAi but are
dispensable in classical RNAi triggered by artificial dsRNA. Since these two genes
cannot be drh-1, which should have been excluded during the screen, we believe that
both genes are novel components of worm antiviral RNAi.
Backcross with wild type N2 worms containing an FR1gfp transgene
F2 worms with the candidate allele F2 worms without the candidate allele
Extract and combine the genomic 
DNA for deep sequencing
Extract and combine the genomic 
DNA for deep sequencing
Alignment to the reference N2 genome to identify genetic mutations
Identification of genetic mutations unique to the mutant pool 
through VCF file manipulation
Annotation of identification of causal mutations using snpEff
FIG 7 Schematic presentation of the workflow for the identification of candidate alleles using the
mapping-by-sequencing strategy. VCF, variant call format. snpEff, a toolbox for genomic variant anno-
tations and functional effect prediction.
FIG 8 Identification of rsd-6 as key component of antiviral RNAi in C. elegans. (A) Schematic gene
structures for wild-type rsd-6 and rsd-6 alleles isolated in the genetic screen. Exons are shown as solid
boxes, whereas the lines indicate introns. The putative protein sizes from conceptual translation are
indicated for each allele. (B) Schematic structure of the plasmid construct that was used for constitutive
expression of wild-type rsd-2 gene in transgenic worms. RSD-6, the open reading frame of wild-type
rsd-6. (C) Ectopic expression of wild-type rsd-6 restored antiviral RNAi in worm mutants containing the
1026a alleles. Shown here is the visualization of green fluorescence in the 1026a mutants that have been
injected with plasmid construct Psur-5::RSD-6. The transgenic worm is marked by red fluorescence in the
head region. (D) Constitutive overexpression of wild-type rsd-6 restored antiviral RNAi in worm mutants
containing the 1026a alleles. Shown here is the detection of FR1gfp genomic and subgenomic RNA
accumulation after heat induction. An asterisk indicates 1026a mutants that contain integrated transgene
derived from the plasmid construct Psur-5::RSD-6. (E) Same as panel D, except that the replication of
Orsay virus RNA1 was detected through Northern blotting. The replication of Orsay virus RNA1 in drh-1
loss-of-function mutants was detected as the reference.
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asd-9 and rsd-6, but not asd-2, are required for the biogenesis or stability of
primary viral siRNAs. In C. elegans, viral dsRNAs are mainly processed into 23-
nucleotide primary vsiRNAs, which can be detected by next-generation sequencing or
Northern blotting (6, 8). As an effort to define a role for asd-2, asd-9, and rsd-6 in
antiviral RNAi, we checked the accumulation of primary vsiRNAs in worm mutants
containing asd-2, asd-9, or rsd-6 alleles. As references we also detected the accumula-
tion of primary vsiRNAs in drh-1, rde-1, and rde-4. Consistent with previous findings (8,
35), vsiRNAs were detected at high level in rde-1 mutants but low level in drh-1 and
rde-4 mutants, although the genomic and subgenomic RNAs of FR1gfp accumulated at
comparable levels in these mutants (Fig. 10A and B). Interestingly, we found that
primary vsiRNAs were barely detectable in asd-9 and rsd-6 mutants but accumulated to
high level in asd-2 mutants (Fig. 10B). When the same blot was stripped and reused for
miR-58 detection, we found that miR-58 accumulated at similar levels in these mutants.
These results together suggest that asd-9 and rsd-6, but not asd-2, are required for the
biogenesis or stability of primary viral siRNAs.
DISCUSSION
Artificial dsRNAs trigger potent silencing of homologous cellular transcripts in
diverse organisms, and mechanistic studies of this phenomenon have significantly
improved our understanding of antiviral RNAi. However, several lines of evidence
suggest that viruses as triggers and targets of RNAi are fundamentally different from
the triggers and targets of RNAi in artificial setups. First, viruses often replicate in
subcellular compartments, and accordingly virus-produced dsRNAs may be physically
isolated from Dicer and cofactors (45). This may explain why antiviral RNAi in C. elegans
requires DRH-1, a functional homologue of mammalian virus sensors. Second, the
nascent viral transcripts often become rapidly associated with viral structure proteins,
such as the coat proteins, and thereby may be protected from Ago-mediated cleavage.
The fact that FR1gfp replication triggers potent silencing of homologous cellular
transgenes in drh-1 mutants further suggests that replicating virus is more resistant to
RNAi than cellular transcripts, even in the absence of viral structural protein (8). These
observations suggest that antiviral RNAi involves more genes than classical RNAi, and
FIG 9 Both asd-2 and asd-9 play important roles in antiviral RNAi targeting Orsay virus. (A) Northern blot
detection of Orsay virus replication in LR11 worms that carry representative alleles corresponding to each
of the candidate genes as indicated. (B) Northern blot detection of Orsay virus replication in candidate
mutants isolated from the generic screen. ovRNA1, Orsay virus RNA1.
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these genes can only be identified in genetic screens that utilize replicating virus as a
loss-of-RNAi reporter.
Using replicating virus as a reporter for the loss of RNAi activity, we identified 9
candidate genes that appear to be dispensable in classical RNAi. Importantly, we found
that among the 9 candidate genes, asd-2 and asd-9 are required for antiviral RNAi
targeting Orsay virus but appear dispensable for classical RNAi. Since the design of our
screen strategy has already excluded drh-1 as a target of our genetic screen, which is
confirmed by drh-1 coding sequence for our candidates, we believe asd-2 and asd-9 are
novel antiviral RNAi genes. Mechanistic study of these two genes may allow us to gain
further insight into the mechanisms by which viruses are detected and destroyed by
the RNAi machinery in C. elegans.
drh-1 transcriptions are not induced in response to replication of FHV (16).
Currently, whether the function of DRH-1 in virus detection undergoes posttrans-
lational regulation remains largely unknown. Recently, Choi and colleagues found
that the C-terminal region of RIG-I, which plays a crucial role in viral dsRNA
detection, undergoes deacetylation to regulate its activity in virus sensing and that
RIG-I deacetylation by HDAC6 (histone deacetylase 6) is critical for viral RNA
detection (46). The residue targeted by HDAC6 for deacetylation is within a KWK
motif that is conserved in both RIG-I and DRH-1. Since the KWK motif is required for
DRH-1 function in antiviral RNAi, it would be interesting to check if DRH-1 also
undergoes deacetylation at this particular residue and whether deacetylation of this
residue is required for DRH-1 function. Nevertheless, this observation suggests that
while its genetic identity awaits further characterization, asd-9, which is required for
the biogenesis or stability of primary vsiRNAs (Fig. 10B), contributes to viral dsRNA
detection by directly or indirectly regulating DRH-1 function.
rsd-6 was originally identified as one of the genes required for the systemic
spreading of RNAi (32). Its role in antiviral RNAi has never been reported. Previously
it has been shown that meiotic chromosome disjunction is affected in rsd-6 mutants
















FIG 10 asd-9 and rsd-6, but not asd-2, are required for biogenesis or stability of primary viral siRNAs. (A)
Accumulation of FR1gfp genomic and subgenomic RNAs in asd-2 (1029e), asd-9 (1026d), and rsd-6
(1026a) after heat induction. The replication of FR1gfp in wild-type N2 worms and drh-1, rde-1, and rde-4
mutants was also detected as references. (B) Northern blot detection of FR1gfp-derived primary siRNAs
in asd-2 (1029e), asd-9 (1026d), rsd-6 (1026a), and control worm strains. The accumulation of miR-58 was
also detected as an equal loading control.
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rsd-6 helps maintain genome integrity in stressful environments by maintaining
transgenerational inheritance of endogenous siRNA populations that promote
genome silencing (44). Consistent with this, we found that all rsd-6 mutants isolated
in our genetic screen produce far fewer progenies at room temperature than
wild-type worms. However, our rsd-6 mutants do not become completely sterile
when reared at 25°C (Table 1). Probably other worm genes, such as rsd-2, partially
compensate for the loss of rsd-6 function in maintaining genome integrity. The fact
that rsd-6 is required for the biogenesis or stability of primary vsiRNAs (Fig. 10B)
suggests that rsd-6 is required for the production of secondary vsiRNAs whose
biogenesis relies on the production and function of primary vsiRNAs. In support of
this hypothesis, rsd-6 was previously found to help maintain the population of a
class of endogenous secondary siRNAs that target and silence genes involved in
spermatogenesis (44).
Previously we have demonstrated that replicating virus is more resistant to RNAi
than cellular transcripts (8), suggesting that the secondary siRNA-mediated ampli-
fication mechanism is more important for RNAi to destroy replicating viruses than
cellular transcripts. rde-10, rde-11, and rsd-2 are 3 genes that are required for the
production of secondary siRNAs. Recently, it has been demonstrated that worm
mutants corresponding to these genes remain sensitive to high dosage of dsRNA
triggers (33, 47), suggesting that a secondary siRNA-mediated gene-silencing effect
would not be detected in a classical RNAi screen where the dosage of the dsRNA
trigger is high. In fact, we also observed that rrf-1 mutants are sensitive to RNAi
triggered by ingestion or injection of dsRNA (Fig. 5F and data not shown). These
observations together suggest that some of our candidate genes that are dispens-
able for classical RNAi mainly contribute to the biogenesis and/or function of
secondary siRNA in antiviral RNAi. We speculate that asd-2 is such an antiviral RNAi
gene. Although its function is not required for the biogenesis or stability of primary
vsiRNAs (Fig. 10B), asd-2 may contribute to the biogenesis and/or function of
secondary vsiRNAs in antiviral RNAi.
Surprisingly, 7 of the candidate genes that are dispensable for classical RNAi do
not confer resistance to intestine-infecting Orsay virus (Fig. 9). To rule out the
possibility that these genes regulate the transcription of the FR1gfp replicon
transgene, thereby suppressing the replication of FR1gfp, we tested the antiviral
activity of candidate genes asd-4 and asd-7 using worms that contain an Orsay virus
replicon transgene driven by a heat-inducible promoter. After heat induction we
did not observe significant increase in Orsay virus replication in asd-4 or asd-7
mutants compared to wild-type worms (F. Meng, unpublished data). Currently it
remains possible that those genes mainly function in nonintestinal cells to confer
virus-specific silencing.
Its short life span and hermaphroditic lifestyle make C. elegans a powerful system
for gene identification through forward genetic screen. However, large-scale for-
ward genetic screen in the C. elegans system is still a time-consuming and labor-
intensive process, mainly because many of the target genes are repeatedly picked
up during the screen, and consequently much effort will be wasted in character-
izing the redundant alleles. By introducing extra copies of known antiviral RNAi
genes into the reporter worm strain, we were able to successfully reject alleles
corresponding to those genes during genetic screen. Since codelivery of multiple
transgenes into C. elegans through gonad microinjection can be done in laborato-
ries with basic microinjection facilities, this strategy can be easily adopted for
identification of novel genes involved in other biological pathways. The small body
size and short life cycle of C. elegans suggest that gene discovery in the C. elegans
system can be easily scaled up to screen a very large number of mutagenized
worms, even in laboratories with limited resources. Thus, our approach combined
with a mapping-by-sequencing strategy will allow for rapid identification of func-
tionally redundant genes and genes with low mutation rates.
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Genetics. N2, a Bristol isolate of wild-type C. elegans, was used as a reference strain in this study.
Other N2-derived mutants used in this study are rde-1(ne300), rde-4(ne337), rsd-2(pk3307), drh-1(tm329),
rrf-1(ok589), and drh-3(ne4253). The genotypes of rde-1, rde-4, and rsd-2 mutants were confirmed by skn-1
feeding RNAi together with DNA sequencing. The genotype for drh-1 and rrf-1 mutants was confirmed
by PCR. The drh-3 mutants are sterile at 25°C and thus are selected based on their temperature sensitivity.
Plasmid constructs and transgenic worms. All plasmid constructs created for constitutive expres-
sion of the antiviral RNAi genes were developed using the PD51 vector as the backbone (8). The
development of Psur-5::drh-1 and Psur-5::rsd-2 has been described previously (8, 31). Plasmids Psur-5::
rde-1 and Psur-5::rde-4 were created by inserting the rde-1 and rde-4 coding sequences, amplified
through reverse transcription-PCR (RT-PCR), into PD51. The resulting constructs were confirmed by DNA
sequencing. The development of FR1gfp replicon was described previously (16).
RNAi assay. All feeding RNAi plates were seeded with bacterial strains, derived from HT115,
engineered to express double-stranded RNA corresponding to the target genes. IPTG (isopropyl--D-
thiogalactopyranoside) at a final concentration of 5 mM was used to induce the production of dsRNA in
HT115. Worms at the L1 or L2 larval stage were transferred onto freshly prepared feeding RNAi plates.
NGM plates containing OP50 food were used as controls in each experiment. To prepare dsRNA for
microinjection, equal amounts of plus- and minus-stranded RNA molecules, synthesized through in vitro
transcription, were combined in ultrapure H2O, denatured in boiling water for 5 min, and annealed at
room temperature. The RNAi phenotypes were recorded for progeny worms collected between 8 and 32
h after microinjection.
Genetic screen. Our genetic screen was carried out by following an established protocol, with some
minor modifications. We treated synchronized L4 worms with 47 M EMS for 6 h to introduce random
mutations into the worm genome. The F1 progenies were then bleached to collect eggs for genetic
screening. All F2 worms that produced green fluorescence after heat induction were picked up and
propagated for reconfirmation. All confirmed mutants were then labeled based on the day they were
identified and subjected to further characterization, such as temperature sensitivity and genetic com-
plementation tests.
Orsay virus inoculum preparation and infection of C. elegans. Orsay virus was maintained in
worm strain JU1580 by following a protocol described previously (14). To prepare infectious Orsay virus
filtrate, infected JU1580 worms were washed off of slightly starved NGM plates using sterilized water.
After a quick low-speed spin to pellet the worms, the supernatant was filtered through 0.22-m filter
units and the filtrate was mixed with OP50 culture for NGM plate seeding.
RNA gel blot analysis for viral RNA detection. The FR1gfp replication in worms containing the
FR1gfp transgene was induced by incubating the transgenic worms at 33°C for 3 h. The total worm RNA
was then extracted with TRI Reagent by following the manufacturer’s instructions (Sigma-Aldrich, Inc.).
The FR1gfp transcripts were then detected using a protocol described previously (38). The detection of
Orsay virus replication was done using the same protocol, except that the cDNA probe was RT-PCR
amplified from the RNA1 of Orsay virus. The primary vsiRNAs were detected using homolog-labeled
oligonucleotide probes as described previously (38).
Candidate allele mapping through whole-genome sequencing. Hermaphrodites carrying the
candidate allele were crossed to N2 males that carry an FR1gfp transgene. Fifty F2 worms that carry
homozygous candidate alleles, namely, the mutant pool, and 50 F2 worms that do not carry the
candidate allele, namely, the wild-type pool, were then singled out and propagated on 60-mm petri
dishes for genomic DNA preparation. After the genomic DNA was extracted for each F2 strain using a
Qiagen DNeasy blood and tissue kit, the genomic DNA was combined at equal amounts to produce a
mutant pool and wild-type pool. To construct libraries for whole-genome sequencing, the combined
genomic DNA was sheared using a Biorupter (15 s on, 90 s off, for 9 cycles). The PCR-free TruSeq DNA
kit (Illumina) then was used to construct libraries for deep sequencing. Six of the genomic DNA libraries
were sequenced on one lane for 161 cycles from one end of the fragments on an Illumina HiSeq 2500
platform. The reads are 160 nucleotides in length. Processing of the Illumina reads, mapping, and
variation identification were performed by following the workflow illustrated in Fig. 7. The wild-type N2
reference genome and annotation used in our study was WormBase release WS235 (http://www
.wormbase.org).
Imaging microscopy. GFP and mCherry fluorescence images were recorded using a Nikon p7000
digital camera mounted on a Nikon SMZ1500 microscope.
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